Rineterkib (compound B) is an orally active inhibitor of ERK1/2 that exerts an antiproliferative effect by activating mutations in the MAPK pathway. This activity is particularly associated with KRAS-mutant non-small cell lung cancer, BRAF-mutant non-sma
Molekulargewicht:
578.42
Reinheit:
>99%
CAS Nummer:
[1715025-32-3]
Formel:
C26H27BrF3N5O2
Target-Kategorie:
ERK
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten